↓ Skip to main content

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

Overview of attention for article published in Stem Cell Research & Therapy, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
Published in
Stem Cell Research & Therapy, March 2022
DOI 10.1186/s13287-022-02796-1
Pubmed ID
Authors

Carmen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Claudio Luciano Franck, Debora Regina Daga, Patrícia Shigunov, Marco Augusto Stimamiglio, Daniela Boscaro Marsaro, Bruna Schaidt, Andressa Micosky, Ana Paula de Azambuja, Cleverson Alex Leitão, Ricardo Rasmussen Petterle, Valderez Ravaglio Jamur, Isadora May Vaz, Antônio Paulo Mallmann, Hipólito Carraro Junior, Eduardo Ditzel, Paulo Roberto Slud Brofman, Alejandro Correa

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 88 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 10%
Researcher 8 9%
Student > Ph. D. Student 6 7%
Student > Master 5 6%
Student > Doctoral Student 3 3%
Other 11 13%
Unknown 46 52%
Readers by discipline Count As %
Medicine and Dentistry 14 16%
Biochemistry, Genetics and Molecular Biology 9 10%
Nursing and Health Professions 4 5%
Agricultural and Biological Sciences 3 3%
Engineering 3 3%
Other 8 9%
Unknown 47 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2022.
All research outputs
#14,336,402
of 23,408,972 outputs
Outputs from Stem Cell Research & Therapy
#1,073
of 2,463 outputs
Outputs of similar age
#207,710
of 440,609 outputs
Outputs of similar age from Stem Cell Research & Therapy
#30
of 83 outputs
Altmetric has tracked 23,408,972 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,463 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,609 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.